Regulatory Story
Company Kainos Group plc
Headline Total Voting Rights
Released 12:11 28-Feb-2019
Number 4556R12

RNS Number : 4556R
Kainos Group plc
28 February 2019

28 February 2019

Kainos Group plc


("Kainos" or the "Company") 

Total Voting Rights

Pursuant to DTR 5.6.1 the Company announces that as at 28 February 2019, the total number of ordinary shares in issue now stands at 121,004,098 each with voting rights. There are no shares held in treasury.


The above figure (121,004,098) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.


Kainos Group Limited Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Classification: 2.5 - Total number of voting rights and capital




For further information, please contact:


Kainos                                                                                         via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer


Investec Bank plc                                                                               +44 20 7597 5970

Patrick Robb / Sebastian Lawrence


Canaccord Genuity                                                                            +44 20 7523 4606

Simon Bridges / Emma Gabriel


FTI Consulting LLP                                                                            +44 20 3727 1000

Matt Dixon / Harry Staight


About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.


The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.


The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.


Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.


Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.